Antihyperlipidemic Drugs Market to Nearly Double by 2032

a adăugat un sunet Alte

2025-11-25 09:03:08 -

The Antihyperlipidemic Drugs Market, forecasting a robust expansion from USD 13.49 billion in 2023 to USD 25.65 billion by 2032, representing a compound annual growth rate (CAGR) of 7.4% over the 2024–2032 period. Key market drivers include a steep increase in hyperlipidemia and cardiovascular disease prevalence globally, coupled with rising adoption of advanced lipid-lowering therapies...

0 Commentarii 0 Distribuiri 4 Views 0 previzualizare